InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: None

Friday, 01/31/2014 9:44:53 AM

Friday, January 31, 2014 9:44:53 AM

Post# of 30990
Article in Forbes on STSI regarding anatabine and the FDA. Author claims that neither Star nor Rock Creek submitted the IND in 2012:

As such, the FDA has ruled that Anatabloc and CigRx are adulterated with an unapproved drug, particularly since an unidentified firm had filed an Investigational New Drug application (IND) with the FDA in June, 2012. The sponsor isn’t Star Scientific or Rock Creek because they are still only talking about filing an IND as of their shareholder meeting at the end of last year. When I contacted FDA for information on the IND sponsor, media officer Juli Putnam reminded me,

"The FDA cannot comment on any current/pending product applications. The FDA is only able to provide information on approved drug product applications. Any information on an application that has yet to receive an approval or was denied approval belongs to the manufacturer/sponsor developing the drug (21 CFR 314.430)."



Article link here:

http://www.forbes.com/sites/davidkroll/2014/01/31/whats-the-dope-on-anatabine-in-star-scientifics-anatabloc-and-cigrx/?partner=yahootix

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.